GlassScriptPhysician profile
Katherina T Chappell
NPI 1942692124
$4,613.79
in general payments reported to CMS, 2019-2025
20 companies · $1,471 in 2025
The $1,471 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.19 · 2022: $547 · 2023: $835 · 2024: $1,734 · 2025: $1,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,871 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,870.60 |
| Education | $168.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $972.01 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $521.75 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $519.60 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $430.26 | 2022-2025 | Absorica Ld, Winlevi |
| Novartis Pharmaceuticals Corporation | $395.89 | 2022-2025 | |
| Leo Pharma INC. | $259.39 | 2023-2025 | Adbry |
| Lilly USA, LLC | $201.82 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Arcutis Biotherapeutics, INC. | $194.53 | 2023-2025 | Zoryve |
| Amgen INC. | $160.34 | 2024-2025 | Otezla, Otezla |
| Incyte Corporation | $154.87 | 2022-2025 | Opzelura |
| Janssen Biotech, INC. | $144.91 | 2021-2025 | Tremfya |
| Epi Health, LLC | $136.00 | 2022 | |
| Dermavant Sciences, INC. | $98.39 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $93.84 | 2024-2025 | Dupixent, Libtayo |
| Pfizer INC. | $93.08 | 2023-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $90.87 | 2022-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $71.92 | 2023-2025 | Jublia |
| Organon LLC | $27.34 | 2025 | Vtama |
| Biocon Biologics INC | $23.95 | 2025 | Yesintek |
| Kyowa Kirin, INC. | $23.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherina Chappell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.